BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 158032)

  • 1. Plasma pancreatic hormone levels in a case of somatostatinoma: diagnostic and therapeutic implications.
    Pipeleers D; Somers G; Gepts W; De Nutte N; De Vroede M
    J Clin Endocrinol Metab; 1979 Oct; 49(4):572-9. PubMed ID: 158032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia.
    Pipeleers D; Couturier E; Gepts W; Reynders J; Somers G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1236-42. PubMed ID: 6132927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin-secreting islet cell tumor (somatostatinoma): suppression of growth hormone (GH) release induced by GH-releasing hormone.
    Iguchi H; Kumagai S; Seo IH; Wakasugi H; Hara Y; Abe M
    J Clin Endocrinol Metab; 1988 Jul; 67(1):206-10. PubMed ID: 2897973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative diagnostic value of the calcium-pentagastrin test versus the tolbutamide test in a patient with a somatostatinoma.
    Budmiger H; Bühler H; Häcki W; Stamm B; Streuli R; Ammann R
    Gastroenterology; 1987 Mar; 92(3):800-4. PubMed ID: 3028898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects.
    Schusdziarra V; Grube D; Seifert H; Galle J; Etzrodt H; Beischer W; Haferkamp O; Pfeiffer EF
    Klin Wochenschr; 1983 Jul; 61(14):681-9. PubMed ID: 6136627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma.
    Patel YC; Ganda OP; Benoit R
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1048-53. PubMed ID: 6137494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of duodenal somatostatinoma: diagnostic usefulness of calcium--pentagastrin test.
    Somers G; Pipeleers-Marichal M; Gepts W; Pipeleers D
    Gastroenterology; 1983 Nov; 85(5):1192-8. PubMed ID: 6137434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatinoma syndrome. Biochemical, morphologic and clinical features.
    Krejs GJ; Orci L; Conlon JM; Ravazzola M; Davis GR; Raskin P; Collins SM; McCarthy DM; Baetens D; Rubenstein A; Aldor TA; Unger RH
    N Engl J Med; 1979 Aug; 301(6):285-92. PubMed ID: 377080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatinoma of the rectum.
    Kitagawa M; Hayakawa T; Kondo T; Shibata T; Sakai Y; Ono H; Kiriyama S; Yokoi T
    Am J Gastroenterol; 1989 Nov; 84(11):1452-5. PubMed ID: 2573269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant pancreatic somatostatinoma in a patient with dermatitis herpetiformis and coeliac disease.
    Levi S; Bjarnason I; Swinson CM; Polak JM; Murray W; Levi AJ
    Digestion; 1988; 39(1):1-6. PubMed ID: 2899527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatinoma syndrome accompanied by overproduction of pancreatic polypeptide.
    Nakanome C; Koizumi M; Fujiya H; Akai H; Toyota T; Goto Y; Kameyama J; Miyakawa K; Hanew K
    Tohoku J Exp Med; 1984 Feb; 142(2):201-10. PubMed ID: 6144197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exocrine pancreatic insufficiency and pancreatic fibrosis due to duodenal somatostatinoma in a patient with neurofibromatosis.
    Hagen EC; Houben GM; Nikkels RE; Jansen JB; Lamers CB; Gooszen HG; van Duinen SG; Meinders AE
    Pancreas; 1992; 7(1):98-104. PubMed ID: 1348357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of sodium valproate on plasma somatostatin and insulin in humans.
    Kusunoki M; Yamamura T; Ichii S; Fujita S; Nakai T; Utsunomiya J
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1060-3. PubMed ID: 2903170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin-producing pancreatic somatostatinoma.
    Galmiche JP; Chayvialle JA; Dubois PM; David L; Descos F; Paulin C; Ducastelle T; Colin R; Geffroy Y
    Gastroenterology; 1980 Jun; 78(6):1577-83. PubMed ID: 6102950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GI hormonal changes in diabetes influence pancreatic cancer growth.
    Fisher WE; Boros LG; O'Dorisio TM; O'Dorisio MS; Schirmer WJ
    J Surg Res; 1995 Jun; 58(6):754-8. PubMed ID: 7791356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic polypeptide-secreting islet-cell tumors. A study of three cases.
    Tomita T; Friesen SR; Kimmel JR; Doull V; Pollock HG
    Am J Pathol; 1983 Nov; 113(2):134-42. PubMed ID: 6314815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of somatostatinoma: responses to food and SMS 201-995 administration.
    Davis TM; Bray G; Domin J; Bloom SR
    Pancreas; 1988; 3(6):729-33. PubMed ID: 2906126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic hormone profiles and metabolism posthepatectomy in the dog. Evidence for a hepatotrophic role of insulin, glucagon, and pancreatic polypeptide.
    Cohen DM; Jaspan JB; Polonsky KS; Lever EG; Moossa AR
    Gastroenterology; 1984 Sep; 87(3):679-87. PubMed ID: 6146553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin-producing pancreatic somatostatinoma: report of a case.
    Sugimoto F; Sekiya T; Saito M; Iiai T; Suda K; Nozawa A; Nakazawa T; Ishizaki T; Ikarashi T
    Surg Today; 1998; 28(12):1279-82. PubMed ID: 9872549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic somatostatinoma diagnosed preoperatively: report of a case.
    Mori Y; Sato N; Taniguchi R; Tamura T; Minagawa N; Shibao K; Higure A; Nakamoto M; Taguchi M; Yamaguchi K
    JOP; 2014 Jan; 15(1):66-71. PubMed ID: 24413789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.